ModivCare price target lowered to $6 from $10 at Barrington

Barrington lowered the firm’s price target on ModivCare (MODV) to $6 from $10 and keeps an Outperform rating on the shares. The company’s Q4 report is a “mixed bag” with no formal outlook for fiscal 2026, the analyst tells investors in a research note. The firm is “encouraged” by ModivCare’s progress in shifting many of its shared risk contracts to fee for service agreements, but concedes “this remains a high-risk investment with various unknowns.”